Zheng Yang1,2, Yang Yang3, Yichi Xu1, Weiqian Jiang1,2, Yan Shao4, Jiahua Xing4, Youbai Chen5, Yan Han6. 1. Department of Plastic Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. 2. Medical School of Chinese PLA, Chinese PLA General Hospital, Beijing, 100853, China. 3. Xi'an Daxing Hospital, Xi'an, 710016, Shaanxi, China. 4. School of Medicine, Nankai University, Tianjin, 300071, China. 5. Department of Plastic Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. youbaichen@foxmail.com. 6. Department of Plastic Surgery, The First Medical Center, Chinese PLA General Hospital, Beijing, 100853, China. 13720086335@163.com.
Abstract
BACKGROUND: Efficient and stable delivery of neurotrophic factors (NTFs) is crucial to provide suitable microenvironment for peripheral nerve regeneration. Neurotrophin-3 (NT-3) is an important NTF during peripheral nerve regeneration which is scarce in the first few weeks of nerve defect. Exosomes are nanovesicles and have been served as promising candidate for biocarrier. In this work, NT-3 mRNA was encapsulated in adipose-derived stem cell (ADSC)-derived exosomes (ExoNT-3). These engineered exosomes were applied as NT-3 mRNA carrier and then were loaded in nerve guidance conduit (ExoNT-3-NGC) to bridge rat sciatic nerve defect. METHOD: NT-3 mRNA was encapsulated in exosomes by forcedly expression of NT-3 mRNA in the donor ADSCs. ExoNT-3 were co-cultured with SCs in vitro; after 24 h of culture, the efficiency of NT-3 mRNA delivery was evaluated by qPCR, western blotting and ELISA. Then, ExoNT-3 were loaded in alginate hydrogel to construct the nerve guidance conduits (ExoNT-3-NGC). ExoNT-3-NGC were implanted in vivo to reconstruct 10 mm rat sciatic nerve defect. The expression of NT-3 was measured 2 weeks after the implantation operation. The sciatic nerve functional index (SFI) was examined at 2 and 8 weeks after the operation. Moreover, the therapeutic effect of ExoNT-3-NGC was also evaluated by morphology assay, immunofluorescence staining of regenerated nerves, function evaluation of gastrocnemius muscles after 8 weeks of implantation. RESULTS: The engineered exosomes could deliver NT-3 mRNA to the recipient cells efficiently and translated into functional protein. The constructed NGC could realize stable release of exosomes at least for 2 weeks. After NGC implantation in vivo, ExoNT-3-NGC group significantly promote nerve regeneration and improve the function recovery of gastrocnemius muscles compared with control exosomes (Exoempty-NGC) group. CONCLUSION: In this work, NGC was constructed to allow exosome-mediated NT-3 mRNA delivery. After ExoNT-3-NGC implantation in vivo, the level of NT-3 could restore which enhance the nerve regeneration. Our study provide a potential approach to improve nerve regeneration.
BACKGROUND: Efficient and stable delivery of neurotrophic factors (NTFs) is crucial to provide suitable microenvironment for peripheral nerve regeneration. Neurotrophin-3 (NT-3) is an important NTF during peripheral nerve regeneration which is scarce in the first few weeks of nerve defect. Exosomes are nanovesicles and have been served as promising candidate for biocarrier. In this work, NT-3 mRNA was encapsulated in adipose-derived stem cell (ADSC)-derived exosomes (ExoNT-3). These engineered exosomes were applied as NT-3 mRNA carrier and then were loaded in nerve guidance conduit (ExoNT-3-NGC) to bridge ratsciatic nerve defect. METHOD: NT-3 mRNA was encapsulated in exosomes by forcedly expression of NT-3 mRNA in the donor ADSCs. ExoNT-3 were co-cultured with SCs in vitro; after 24 h of culture, the efficiency of NT-3 mRNA delivery was evaluated by qPCR, western blotting and ELISA. Then, ExoNT-3 were loaded in alginate hydrogel to construct the nerve guidance conduits (ExoNT-3-NGC). ExoNT-3-NGC were implanted in vivo to reconstruct 10 mm ratsciatic nerve defect. The expression of NT-3 was measured 2 weeks after the implantation operation. The sciatic nerve functional index (SFI) was examined at 2 and 8 weeks after the operation. Moreover, the therapeutic effect of ExoNT-3-NGC was also evaluated by morphology assay, immunofluorescence staining of regenerated nerves, function evaluation of gastrocnemius muscles after 8 weeks of implantation. RESULTS: The engineered exosomes could deliver NT-3 mRNA to the recipient cells efficiently and translated into functional protein. The constructed NGC could realize stable release of exosomes at least for 2 weeks. After NGC implantation in vivo, ExoNT-3-NGC group significantly promote nerve regeneration and improve the function recovery of gastrocnemius muscles compared with control exosomes (Exoempty-NGC) group. CONCLUSION: In this work, NGC was constructed to allow exosome-mediated NT-3 mRNA delivery. After ExoNT-3-NGC implantation in vivo, the level of NT-3 could restore which enhance the nerve regeneration. Our study provide a potential approach to improve nerve regeneration.
Authors: Christopher J Pateman; Adam J Harding; Adam Glen; Caroline S Taylor; Claire R Christmas; Peter P Robinson; Steve Rimmer; Fiona M Boissonade; Frederik Claeyssens; John W Haycock Journal: Biomaterials Date: 2015-02-14 Impact factor: 12.479
Authors: Erin-Mai F Lim; Stan T Nakanishi; Vahid Hoghooghi; Shane E A Eaton; Alexandra L Palmer; Ariana Frederick; Jo A Stratton; Morgan G Stykel; Patrick J Whelan; Douglas W Zochodne; Jeffrey Biernaskie; Shalina S Ousman Journal: Proc Natl Acad Sci U S A Date: 2017-01-30 Impact factor: 11.205
Authors: Ohan S Manoukian; Jiana T Baker; Swetha Rudraiah; Michael R Arul; Anthony T Vella; Abraham J Domb; Sangamesh G Kumbar Journal: J Control Release Date: 2019-11-19 Impact factor: 9.776